Renflexis (infliximab-abda) for injection 100mg/vialRenflexis (infliximab-abda) for injection 100mg/vial
Quantity
Get it to Germany within 10 working days with standard delivery.
Fast delivery to Germany
Easy Returns & Exchanges
Ask About This Product
Condition : New
0
From UAE
To Germany
in 5-10 days
Description
Renflexis (infliximab-abda) is a biosimilar to Remicade, used for the treatment of various inflammatory autoimmune diseases. Each vial contains 100 mg of infliximab-abda, a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-alpha), a cytokine involved in systemic inflammation. By inhibiting TNF-alpha, Renflexis helps to reduce inflammation and manage symptoms of autoimmune diseases.
How It Works
Infliximab-abda is a chimeric monoclonal antibody that binds specifically to TNF-alpha, blocking its interaction with TNF receptors on cell surfaces. TNF-alpha is a key cytokine in the inflammatory process, and its inhibition reduces inflammation and modulates the immune response. This action helps to alleviate symptoms and prevent disease progression in conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.Indications
- Rheumatoid arthritis
- Crohn’s disease
- Ulcerative colitis
- Ankylosing spondylitis
- Psoriatic arthritis
- Plaque psoriasis
Contraindications
- Hypersensitivity to infliximab or any of its components
- Moderate to severe heart failure
- Active infections, including tuberculosis
Side Effects
- Infusion-related reactions (fever, chills, pruritus)
- Upper respiratory tract infections
- Headache
- Abdominal pain
- Increased liver enzymes
- Rash
- Fatigue
- Urinary tract infections
- Nausea
- Back pain
Price in Different Countries
| Country | Price (per 100mg/vial) | References |
|---|---|---|
| United States | $750 | GoodRx Renflexis Price |
| United Kingdom | £600 | NHS Renflexis Price |
| Canada | $1,000 | Canada Drugs Renflexis Price |
| Australia | $950 | PBS Renflexis Price |
| India | ₹50,000 | 1mg Renflexis Price |
Top 5 Global Brands
- Renflexis (Samsung Bioepis/Merck): The biosimilar to Remicade, used for the treatment of various inflammatory autoimmune diseases.
- Remicade (Janssen Biotech, Inc.): The original brand of infliximab, widely used for treating autoimmune conditions.
- Inflectra (Pfizer): Another biosimilar to Remicade, providing similar therapeutic benefits.
- Remsima (Celltrion Healthcare): A biosimilar infliximab used for treating autoimmune diseases, available in various markets.
- Flixabi (Biogen): Another infliximab biosimilar, used in the management of inflammatory autoimmune diseases.